Investor Day

A surge in healthcare job applications offers a prime opportunity, but new data reveals a critical bottleneck preventing companies from turning interest into hires.

With major conferences ahead, clinical-stage MBX Biosciences aims to impress investors with its promising peptide therapies for endocrine and metabolic disorders.

A new report shows many Americans are ditching pricey V-Day gifts to pay down debt, revealing a deep economic divide reshaping how we celebrate love.

The expanded credit facility provides fintech leader Upgrade with enhanced capital to scale its consumer lending platform, fueling its rapid market expansion.

IBS announces its 2026 MBA/PGPM selection process. We explore its unique methods, global rankings, and what it takes to join its prestigious alumni.

Amid warnings of a funding cliff, the government is set to announce new support for women's groups. Will it be enough to ensure their long-term survival?

With a new focus on eye disease and fresh funding, Surrozen will present its novel Wnt-based pipeline to investors. What's at stake for the future of sight?

Fold's new app aims to make bitcoin simple for daily use, but can it stand out in a crowded market and deliver on its long-term promises?

As Telix prepares its 2025 financials, all eyes are on its blockbuster revenue, pipeline progress, and its leading role in the booming radiopharma sector.

As the hospitality sector faces headwinds, a Philadelphia wine school is hiring and shifting to deeper, semester-long courses to meet surging demand.

As X4 Pharmaceuticals preps for a key investor summit, all eyes are on its pivotal trial for chronic neutropenia and the commercial fate of XOLREMDI®.

With a major investment plan underway, Tallinna Vesi's upcoming 2025 financial report is set to reveal the impact on profits, dividends, and Tallinn's future.

As Bladex prepares its Q4 2025 results, all eyes are on the bank's performance as a key indicator of regional economic health and future investment.

Entegris confirms its quarterly dividend, a sign of financial stability. But what does this move reveal about its debt reduction, growth, and industry position?